Skip to main content
EMVISION MEDICAL DEVICES LTD logo

EMVISION MEDICAL DEVICES LTD — Investor Relations & Filings

Ticker · EMV ISIN · AU0000028375 ASX Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2022-09-15 Regulatory Filings
Country AU Australia
Listing ASX EMV

About EMVISION MEDICAL DEVICES LTD

https://emvision.com.au/

EMVision Medical Devices Ltd is a medical technology company focused on the development and commercialization of portable medical imaging devices. The company specializes in electromagnetic microwave imaging technology designed for the rapid diagnosis and monitoring of stroke and traumatic brain injury. Its primary product is a portable brain scanner intended for use at the point of care, including intensive care units, emergency departments, and ambulances. By utilizing non-ionizing radiation, the technology provides a safe, cost-effective, and mobile alternative to traditional neuroimaging modalities like CT and MRI. The device aims to facilitate earlier clinical intervention by enabling bedside assessment, potentially improving patient outcomes through faster detection of ischemic and hemorrhagic strokes.

Recent filings

Filing Released Lang Actions
Cleansing Notice 1 page 128.4KB
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the issuance of shares pursuant to the exercise of performance rights under an employee incentive plan. It references compliance with sections of the Corporations Act related to securities issuance and disclosure exemptions. It also mentions an Appendix 2A announcement related to the share issue. The document does not contain financial statements, management discussion, or detailed financial data. It is primarily a regulatory notice about a share issuance event and compliance with disclosure laws. Given the short length (1622 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) rather than a full financial report or capital update filing. It is not a Capital/Financing Update (CAP) because it does not detail fundraising or capital structure changes beyond the share issuance notice, and it is not a Share Issue/Capital Change (SHA) because the main announcement of the share issue is in the Appendix 2A, which is referenced but not included here. Therefore, the best classification is Regulatory Filings (RNS).
2022-09-15 English
Investor Presentation - E&P Healthcare Conference 25 pages 3.6MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation by EMVision Medical Devices Limited for the E&P Healthcare Conference in September 2022. It includes company background, product overview, market opportunity, capital structure, and forward-looking statements. The content is structured as a presentation with slides, images (not included), and detailed descriptions of the company's technology and market potential. There are no financial statements, audit opinions, or regulatory certifications. The document is not an earnings release or annual/interim report. It is clearly a presentation aimed at investors and stakeholders to explain the company's strategy, products, and market position. Therefore, the document fits the definition of an Investor Presentation (IP).
2022-09-05 English
Appendix 4E & Annual Report to 30 June 2022 50 pages 2.2MB
Annual Report Classification · 100% confidence The document is titled 'Annual Report – 30 June 2022' and contains detailed financial information including revenue, loss, operating expenses, cash flows, net assets, and a directors' report for the fiscal year ended 30 June 2022. It includes a CEO & Chairman's letter, a review of operations, financial results, and audit information. The length of the document is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of comprehensive financial data and management discussion confirms this is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2022-08-29 English
Appendix 4G & Corporate Governance Statement 25 pages 528.4KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a governance-related disclosure document that serves as a key to where corporate governance disclosures can be found, and it is lodged alongside the annual report. The document explicitly states it is not a substitute for the corporate governance statement but a verification tool. It contains detailed tables indicating compliance with governance recommendations, referencing the corporate governance statement and annual report for further details. The document is about corporate governance disclosures and compliance with ASX Listing Rules, not the full annual report or financial statements. It is a regulatory filing related to governance disclosures but does not itself contain the full governance report or financial data. Given the nature and content, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not neatly fit into other categories, especially governance-related appendices and compliance disclosures.
2022-08-29 English
$5m Modern Manufacturing Initiative Grant Proceeding 2 pages 144.6KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement dated 29/08/22 from EMVision Medical Devices Ltd regarding the progress of a $5 million Modern Manufacturing Initiative (MMI) grant. It provides an update on the grant award, the expected funding amounts in the current and following financial years, and the company's ongoing work to finalize funding documentation. The document does not contain any financial statements, detailed financial performance data, or comprehensive report content. It is a brief update on a financing-related matter, specifically a grant proceeding, which fits the category of a Capital/Financing Update. The document length is about 5,027 characters, which is sufficient for a short announcement but does not qualify as a full financial report or detailed investor presentation. There is no indication that this is a report publication announcement or a regulatory filing of a different nature. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-08-28 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 332.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'APPENDIX 4C – 30 JUNE 2022 QUARTERLY ACTIVITIES & CASHFLOW REPORT' and provides detailed quarterly operational and cash flow information for EMVision Medical Devices Ltd. It includes financial data such as cash reserves, operating cash flows, grant funding, milestone payments, and expenditure breakdowns for the quarter ending 30 June 2022. The document also discusses business activities, clinical trial progress, product development, and strategic agreements during the quarter. The length is substantial (15,000 characters), and it contains substantive financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or a certification, but a comprehensive quarterly report with financial and operational details. Q4 2022
2022-07-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.